Skip to content

Clinical study for the adjuvant treatment of asthma with OPC

Clinical study for the adjuvant treatment of asthma with OPC

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023142
Enrollment
Unknown
Registered
2019-05-13
Start date
2016-04-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

placebo group:Simulator of grape seed Capsule
high-dosage grape seed groups:Grape seed capsule 200 mg/d
low-dosage grape seed groups:Grape seed capsule 100 mg/d

Sponsors

The Affiliated Jiangyin Hospital of Southeast University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. signing the informed consent voluntarily; 2. Aged 18 to 65 years old male and female; 3. According to the criteria defined by GINA, asthma was diagnosed at least for 3 months; 4. The heart, lung, liver and kidney functions are basically normal.

Exclusion criteria

Exclusion criteria: 1. Unable to cooperate with related inspection of the project or unable to cooperate for other reasons; 2. Complicated with any of the following diseases: lung cancer, pneumonia, tuberculosis or severe immunodeficiency; 3. Complicated with heart, lung, liver, kidney severe insufficiency; 4. Any condition that may affect the effectiveness of informed participation in this study, such as a history of alcohol or narcotic drug abuse, or a history of mental illness, antagonistic personality, or other emotional or intellectual problems; 5. Women in pregnancy; 6. Those who participated in other clinical trials within 3 months before the trial.

Design outcomes

Primary

MeasureTime frame
immunoglobulin E;tumor necrosis factor-alpha;interleukin 4;interleukin 13;

Countries

China

Contacts

Public ContactZeng Xiaoning

The First Affiliated Hospital of Nanjing Medical University

zeng_xiao_ning@hotmail.com+86 025 68136269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026